Direct and Indirect Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Invasive Pneumococcal Disease (IPD) Among Children and Adults in the U.S.

BACKGROUND: In February 2010, PCV13 was introduced for routine use among children aged < 5 years. In June 2012, PCV13 was recommended for use in series with 23-valent polysaccharide vaccine (PPSV23) for adults ≥19 years with select medical conditions, and in August 2014, for all adults ≥65 years....

Descripción completa

Detalles Bibliográficos
Autores principales: Pilishvili, Tamara, Gierke, Ryan, Farley, Monica, Schaffner, William, Thomas, Ann, Reingold, Arthur, Harrison, Lee, Lynfield, Ruth, Zansky, Shelley M, Petit, Susan, Miller, Lisa, Baumbach, Joan, Beall, Bernard, Whitney, Cynthia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632075/
http://dx.doi.org/10.1093/ofid/ofx162.158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632075/
http://dx.doi.org/10.1093/ofid/ofx162.158

Ejemplares similares